- Home
- RVPHW vs SBSI Comparison
RVPHW vs SBSI Comparison
Compare RVPHW & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- SBSI
- Stock Information
- Founded
- RVPHW 2018
- SBSI 1960
- Country
- RVPHW United States
- SBSI United States
- Employees
- RVPHW 14
- SBSI N/A
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- SBSI Major Banks
- Sector
- RVPHW Health Care
- SBSI Finance
- Exchange
- RVPHW Nasdaq
- SBSI Nasdaq
- Market Cap
- RVPHW N/A
- SBSI 874.1M
- IPO Year
- RVPHW N/A
- SBSI N/A
- Fundamental
- Price
- RVPHW $0.04
- SBSI $30.90
- Analyst Decision
- RVPHW
- SBSI Hold
- Analyst Count
- RVPHW 0
- SBSI 2
- Target Price
- RVPHW N/A
- SBSI $37.00
- AVG Volume (30 Days)
- RVPHW 22.4K
- SBSI 117.3K
- Earning Date
- RVPHW 03-14-2025
- SBSI 07-24-2025
- Dividend Yield
- RVPHW N/A
- SBSI 4.63%
- EPS Growth
- RVPHW N/A
- SBSI 7.94
- EPS
- RVPHW N/A
- SBSI 2.91
- Revenue
- RVPHW N/A
- SBSI $254,817,000.00
- Revenue This Year
- RVPHW N/A
- SBSI $10.28
- Revenue Next Year
- RVPHW N/A
- SBSI $5.20
- P/E Ratio
- RVPHW N/A
- SBSI $10.70
- Revenue Growth
- RVPHW N/A
- SBSI 6.49
- 52 Week Low
- RVPHW $0.13
- SBSI $25.85
- 52 Week High
- RVPHW $0.15
- SBSI $38.00
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- SBSI 64.77
- Support Level
- RVPHW N/A
- SBSI $30.72
- Resistance Level
- RVPHW N/A
- SBSI $31.32
- Average True Range (ATR)
- RVPHW 0.00
- SBSI 0.56
- MACD
- RVPHW 0.00
- SBSI 0.16
- Stochastic Oscillator
- RVPHW 0.00
- SBSI 84.67
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.